Institute of Arthritis Research in Integrative Medicine

The Institute of Arthritis Research (IAR) is a specialized clinical research organization and research site based in Mackenbach, Germany, focusing on rheumatology, osteology, and immunology. Founded by Dr. Wolfgang Brückle, the institute conducts Phase 2 through Phase 4 clinical trials for pharmaceutical and biotechnology companies targeting inflammatory and degenerative joint diseases. IAR provides comprehensive clinical trial management services, including patient recruitment, data collection, and regulatory compliance within the field of integrative and traditional rheumatology. The institute is recognized for its expertise in evaluating novel therapeutics for conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.